SS Innovations International (SSII) Return on Capital Employed Growth (3y) (2020 - 2026)
SS Innovations International (SSII) Return on Capital Employed Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -846.00 |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -247.00 |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 1,318.00 |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | - |
| 10 | SS Innovations International | 687.99 Mn | 664.38 Mn | 5.33 Mn | 26,965.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,965.00 |
| Dec 31, 2025 | -7,946.00 |
| Sep 30, 2025 | -46,952.00 |
| Jun 30, 2025 | 152,677.00 |
| Mar 31, 2025 | 101,635.00 |
| Dec 31, 2024 | 147,737.00 |
| Sep 30, 2024 | -30,763.00 |
| Jun 30, 2024 | -29,162.00 |
| Mar 31, 2024 | -27,680.00 |
| Dec 31, 2023 | -20,703.00 |
| Sep 30, 2023 | -22,520.00 |
| Jun 30, 2023 | -102,660.00 |
| Mar 31, 2023 | -48,322.00 |
| Dec 31, 2022 | -10,972.00 |
| Sep 30, 2022 | 122,018.00 |
| Jun 30, 2022 | -45,668.00 |
| Mar 31, 2022 | 60,615.00 |
| Dec 31, 2021 | 257,512.00 |
| Sep 30, 2021 | 9,897.00 |
| Jun 30, 2021 | 31,236.00 |